塞德斯醫療 CLDX 深 滬
已收盤 09-19 16:00:00 美东时间
41.16
-0.690
-1.65%
華盛通- 最 高43.02
- 今 開42.89
- 成交量 120.99万股
- 最 低 40.82
- 昨 收 41.85
- 總市值 27.04亿
- 52周最高 53.18
- 市盈率 靜 --
- 換手率 1.84%
- 52周最低 22.11
- 委 比 38.41%
- 總股本 6569.87万
- 歷史最高 582.60
- 量 比 1.46
- 振 幅 5.26%
- 歷史最低 1.50
- 每 手 1
- 風險率 6.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多塞德斯医疗盘中异动 股价大跌5.02%
北京时间2024年08月15日02时48分，塞德斯医疗（CLDX.us）股票出现异动，股价快速下跌5.02%。截至发稿，该股报31.61美元/股，成交量19....
08-15 02:48
7 Analysts Have This To Say About Celldex Therapeutics
7 analysts have shared their evaluations of Celldex Therapeutics (NASDAQ:CLDX) ...
08-12 20:01
Celldex Therapeutics Q2 EPS $(0.54) Beats $(0.60) Estimate, Sales $2.50M Beat $820.43K Estimate
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.60) by 10 percent. This is a 16.92 percent increase over losses of $(0.65) per share from
08-09 05:08
快讯 | 塞德斯医疗第二季度运营收入美元-4631.7万
Celldex Therapeutics Q2 Operating Income USD -46.317 Million
08-09 04:01
快讯 | 塞德斯医疗第二季度每股收益美元指数-0.54，与IBES预估值美元指数-0.59相比。
Celldex Therapeutics Q2 EPS USD -0.54 Vs. IBES Estimate USD -0.59
08-09 04:01
快讯 | 塞德斯医疗Q2营业费用美元指数4881.5万
Celldex Therapeutics Q2 Operating Expenses USD 48.815 Million
08-09 04:01
Analysts’ Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Celldex (CLDX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
08-01 14:21
Insiders Who Sold US$2.1m Of Celldex Therapeutics Made The Right Call
While it's been a great week for Celldex Therapeutics, Inc. (NASDAQ:CLDX) share...
07-30 20:25
TD Cowen Remains a Buy on Celldex (CLDX)
TD Cowen analyst Yaron Werber maintained a Buy rating on Celldex (CLDX – Resear...
07-30 19:26
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Shares of F5, Inc. (NASDAQ:FFIV) shares rose sharply in today's pre-market trad...
07-30 17:50
